Anti-inflammatory effects of cannabidiol in the treatment of type 1 diabetes: A mini review
Abstract This study reviews the anti-inflammatory potential of cannabidiol (CBD) in the management of type 1 diabetes (T1D). A comprehensive…
Type 1 diabetes mellitus
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans
Abstract Aims/hypothesis: Insulitis, a hallmark of inflammation preceding autoimmune type 1 diabetes, leads to the eventual loss of functional beta…
Recent Rates of Substance Use Among Adolescents and Young Adults with Type 1 Diabetes in the USA
Abstract Purpose of Review: Substance use is a major public health problem in adolescents and young adults (AYA) and is…
Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
Abstract Type 1 diabetes mellitus (T1DM) is an autoimmune disease resulting from loss of insulin-secreting β-cells in islets of Langerhans.…
Detrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice
Abstract Anti-inflammatory and antidiabetogenic properties have been ascribed to cannabidiol (CBD). CBD-based medicinal drugs have been approved for over a…
The effects of recreational cannabis use on glycemic outcomes and self-management behaviours in people with type 1 and type 2 diabetes: a rapid review
Abstract Background: Recent surveys of Canadian cannabis users reflect increasing consumption rates, some of whom may have diabetes. However, healthcare…
Recreational Cannabis Usage Among Young Adults Living with Diabetes: Protocol for a Mixed Methods Study
Abstract Background: Canada is the second country in the world to legalize recreational cannabis (marijuana). Young adults are the highest…